Infographic: Inappropriate prescribing of antidepressants in children and adolescents

Prescribing of antidepressants in children and adolescents has increased in recent years despite being linked to an increased risk of suicide-related behaviours, a new study reveals.

The study assessed antidepressant prescribing trends in children and young people in Denmark, Germany, the Netherlands, the UK and the US.
The study assessed antidepressant prescribing trends in children and young people in Denmark, Germany, the Netherlands, the UK and the US.

Government warnings in 2004 saw reductions in antidepressant use among children in several countries over concerns some drugs could lead to suicidal ideation. This trend was short lived, however, with a new study showing that antidepressant use among children and adolescents has recently increased substantially in five Western countries.

The study reveals that there was a 54% increase between 2005 and 2012 in the number of young people prescribed antidepressants in the UK.

NICE issued guidance on the management of depression in children and young people in 2005. According to NICE's recommendations, antidepressant medication should not be used for the initial treatment of children and young people with mild depression. The updated 2015 version of the guideline states that antidepressants should not be offered to a child or young person with moderate to severe depression except in combination with a concurrent psychological therapy. 

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases